Skip to main content
. 2023 Feb 2;112(5):1345–1350. doi: 10.1016/j.xphs.2023.01.019

Figure 1.

Fig 1:

Graphical visualization of Abstract. The current landscape of SARSCOV2 vaccines based on multiple modalities and the measures of protective immunity and the immune cells involved in propagation of immune response. The considerations for next generation of vaccines by considering the identified gaps are also presented.